June 2008

 

Issue

Supplement

CHIEF MEDICAL EDITOR'S PAGE

Embolization Therapies

By Barry T. Katzen, MD, Chief Medical Editor

FEATURED TECHNOLOGY

Sponsored by CeloNova BioSciences, Inc.

Embozene™ Color-Advanced Microspheres

The spherical embolic platform for today and the future.

AV/DIALYSIS ACCESS UPDATE

The Role of Surface Coatings on Central Venous and Hemodialysis Catheters

Antimicrobial and antithrombogenic coatings have been developed to combat catheter-related infection and thrombosis, but do they work?

By Abigail Falk, MD

Vein Preservation and Alternative Venous Access

Exploring the options for patients with chronic kidney disease.

By Theodore F. Saad, MD

COVER STORY

Do Particle Size and Type Matter?

Lessons learned from experience with uterine artery embolization.

By Robert L. Worthington-Kirsch, MD

Endovascular Repair of PAVM by Embolotherapy

In a patient with a transient ischemic attack or stroke, a positive contrast echocardiogram does not always mean a patent foramen ovale.

By Robert I. White, Jr, MD

Endovascular Treatment of Cerebral Aneurysms

Current devices, emerging therapies, and future technology for the management of cerebral aneurysms.

By David Fiorella, MD, PhD; Michael E. Kelly, MD; Raymond D. Turner IV, MD; and Pedro Lylyk, MD

Visceral Arterial Embolization

Innovations in new techniques, embolic agents, and delivery systems expand endovascular treatment options for challenging visceral vascular lesions.

By Eric J. Gandras, MD; Craig R. Greben, MD; Daniel Putterman, MD; Drew Caplin, MD; and Avi Setton, MD

Yttrium-90 Radioembolization

Recent advances in hepatic embolotherapy.

By David M. Liu, MD, FRCP(C); David N. Cade, MD; Jesse Knight, MD; Rodney Raabe, MD; Stephen Kee, MD; Andrew Kennedy, MD, FACRO; and Riad Salem, MD, FSIR, MBA

FEATURED TECHNOLOGY

Sponsored by CeloNova BioSciences, Inc.

40-µm Tightly Calibrated Embozene™ Color-Advanced Microspheres

New technical and clinical possibilities in transarterial embolization of liver tumors: Bland and microsphere-enhanced chemoembolization.

An Interview with Kenneth Rosenfield, MD

An expert asserts the importance of trials and registries, reflecting on lessons learned from his own experience, and discusses this year's VIVA meeting.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.